Novel Signaling for Ca2+ and Release in Airway Myocytes

气道肌细胞中 Ca2 和释放的新信号传导

基本信息

  • 批准号:
    7214671
  • 负责人:
  • 金额:
    $ 33.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-04-15 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cholinergic nerves provide a predominant neural control of airway smooth muscle cells (ASMCs) through muscarinic receptors. Simulation of these receptors results in the activation of phospholipase C (PLC) and generation of inositol 1,4,5-triphophate (IP3), which induces Ca2+ release through IP3 receptors (IP3Rs). This well-known signaling pathway is important for muscarinic Ca2+ release and contraction in ASMCs. However, our preliminary study, together with previous findings, suggests that muscarinic stimulation may activate ADP-ribosyl cyclase and then produce cyclic ADP-ribose (cADPR), which induces Ca2+ release from the SR by opening RyRs directly and/or indirectly by disassociating FK506 binding protein 12.6 (FKBP12.6) from these Ca2+ release channels, leading to the amplification of muscarinic Ca2+ release and associated contraction in ASMCs. This novel signaling pathway, ADP-ribosyl cyclase-cADPR-FKBP12.6-RyR, may be hyper-functioned in asthma, contributing to the airway muscle Ca2+ and contractile hyperresponsiveness to muscarinic agonists and other numerous spasomogens. To test these hypotheses, we will address the following questions (specific aims): (1) Does cADPR mediate muscarinic Ca2+ release in normal and asthmatic ASMCs? (2) Is FKBP12.6 required for muscarinic Ca2+ release and the target for cADPR in normal and asthmatic ASMCs? and (3) which subtype of RyRs involves muscarinic Ca2+ release and the roles of cADPR and FKBP12.6 in normal and asthmatic ASMCs? These aims will be implemented using simultaneous measurements of Ca2+ sparks or whole-cell [Ca2+]i and membrane currents in freshly disassociated airway myocytes. Genetic manipulations (gene overexpression and knockout), molecular biological and biochemical methods will be also used in this proposal. This study will extend our understanding of the cellular and molecular mechanisms underlying muscarinic Ca2+ release in normal and asthmatic ASMCs, and may also identify novel therapeutic targets for asthma attacks. Since cADPR, FKBP12.6, and/or RyRs are ubiquitously expressed in a variety of cell types, the mechanistic findings from the proposed study will have general biological and pathological significance for various Ca2+-mediated cellular effects.
描述(由申请人提供):

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inositol 1,4,5-trisphosphate activates TRPC3 channels to cause extracellular Ca2+ influx in airway smooth muscle cells.
Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.
钙调神经磷酸酶通过气道平滑肌细胞中的兰尼定受体 1 上调局部 Ca(2) 信号传导。
Potential important roles and signaling mechanisms of YPEL4 in pulmonary diseases.
  • DOI:
    10.1186/s40169-018-0194-5
  • 发表时间:
    2018-06-11
  • 期刊:
  • 影响因子:
    10.6
  • 作者:
    Truong L;Zheng YM;Song T;Tang Y;Wang YX
  • 通讯作者:
    Wang YX
Molecular expression and functional role of canonical transient receptor potential channels in airway smooth muscle cells.
Methods to measure and analyze ciliary beat activity: Ca2+ influx-mediated cilia mechanosensitivity.
  • DOI:
    10.1007/s00424-012-1164-1
  • 发表时间:
    2012-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Li WE;Chen W;Ma YF;Tuo QR;Luo XJ;Zhang T;Sai WB;Liu J;Shen J;Liu ZG;Zheng YM;Wang YX;Ji G;Liu QH
  • 通讯作者:
    Liu QH
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YONG-XIAO WANG其他文献

YONG-XIAO WANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YONG-XIAO WANG', 18)}}的其他基金

Cerebral vascular calcium signaling in diabetic Alzheimer's disease-related dementias
糖尿病阿尔茨海默病相关痴呆的脑血管钙信号传导
  • 批准号:
    10117843
  • 财政年份:
    2021
  • 资助金额:
    $ 33.71万
  • 项目类别:
Novel signaling in chronic hypoxic responses in pulmonary arteries
肺动脉慢性缺氧反应的新信号传导
  • 批准号:
    9186562
  • 财政年份:
    2014
  • 资助金额:
    $ 33.71万
  • 项目类别:
Novel signaling in chronic hypoxic responses in pulmonary arteries
肺动脉慢性缺氧反应的新信号传导
  • 批准号:
    8979717
  • 财政年份:
    2014
  • 资助金额:
    $ 33.71万
  • 项目类别:
Novel signaling in chronic hypoxic responses in pulmonary arteries
肺动脉慢性缺氧反应的新信号传导
  • 批准号:
    8825232
  • 财政年份:
    2014
  • 资助金额:
    $ 33.71万
  • 项目类别:
Signaling Mechanisms for Hypoxic Pulmonary Vasoconstriction
缺氧肺血管收缩的信号机制
  • 批准号:
    8389620
  • 财政年份:
    2012
  • 资助金额:
    $ 33.71万
  • 项目类别:
Signaling Mechanisms for Hypoxic Pulmonary Vasoconstriction
缺氧肺血管收缩的信号机制
  • 批准号:
    8598510
  • 财政年份:
    2012
  • 资助金额:
    $ 33.71万
  • 项目类别:
Signaling Mechanisms for Hypoxic Pulmonary Vasoconstriction
缺氧肺血管收缩的信号机制
  • 批准号:
    8237425
  • 财政年份:
    2012
  • 资助金额:
    $ 33.71万
  • 项目类别:
Signaling Mechanisms for Hypoxic Pulmonary Vasoconstriction
缺氧肺血管收缩的信号机制
  • 批准号:
    8882527
  • 财政年份:
    2012
  • 资助金额:
    $ 33.71万
  • 项目类别:
Mechanisms for hypoxic Ca2+ release in pulmonary artery myocytes
肺动脉肌细胞缺氧释放Ca2+的机制
  • 批准号:
    7839422
  • 财政年份:
    2009
  • 资助金额:
    $ 33.71万
  • 项目类别:
Heterogeneity of hypoxic Ca2+ release in pulmonary and *
肺和 * 中缺氧 Ca2 释放的异质性
  • 批准号:
    7104320
  • 财政年份:
    2003
  • 资助金额:
    $ 33.71万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.71万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了